Zacks Research Has Negative Outlook of Stratasys Q2 Earnings

Stratasys Ltd. (NASDAQ:SSYS) – Zacks Research lowered their Q2 2026 earnings estimates for Stratasys in a note issued to investors on Wednesday, February 12th. Zacks Research analyst R. Department now forecasts that the technology company will earn $0.25 per share for the quarter, down from their prior estimate of $0.28. The consensus estimate for Stratasys’ current full-year earnings is ($0.40) per share.

Stratasys (NASDAQ:SSYS) last issued its quarterly earnings data on Wednesday, November 13th. The technology company reported $0.01 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.05. The company had revenue of $140.00 million for the quarter, compared to the consensus estimate of $139.49 million. Stratasys had a negative return on equity of 3.75% and a negative net margin of 16.13%. The firm’s revenue for the quarter was down 13.6% compared to the same quarter last year. During the same quarter last year, the company earned ($0.05) earnings per share.

A number of other brokerages have also weighed in on SSYS. Needham & Company LLC reissued a “buy” rating and issued a $12.00 price objective on shares of Stratasys in a report on Monday, February 3rd. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $12.00 price objective on shares of Stratasys in a report on Monday, February 3rd. StockNews.com cut shares of Stratasys from a “buy” rating to a “hold” rating in a report on Monday. Finally, Craig Hallum boosted their price objective on Stratasys from $12.00 to $15.00 and gave the company a “buy” rating in a report on Thursday, November 14th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $11.40.

Stratasys Stock Up 1.8 %

NASDAQ SSYS opened at $11.77 on Friday. The firm has a market cap of $840.14 million, a PE ratio of -8.92 and a beta of 1.31. Stratasys has a 52 week low of $6.05 and a 52 week high of $13.98. The company has a 50 day moving average price of $9.88 and a 200 day moving average price of $8.56.

Institutional Trading of Stratasys

A number of institutional investors have recently made changes to their positions in the company. Pinnacle Associates Ltd. lifted its position in Stratasys by 0.4% during the third quarter. Pinnacle Associates Ltd. now owns 1,050,639 shares of the technology company’s stock worth $8,731,000 after buying an additional 3,791 shares in the last quarter. ARK Investment Management LLC raised its position in shares of Stratasys by 0.7% during the 3rd quarter. ARK Investment Management LLC now owns 647,221 shares of the technology company’s stock valued at $5,378,000 after buying an additional 4,589 shares during the period. RPG Investment Advisory LLC increased its stake in Stratasys by 29.6% during the third quarter. RPG Investment Advisory LLC now owns 659,996 shares of the technology company’s stock worth $5,485,000 after acquiring an additional 150,891 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. lifted its stake in shares of Stratasys by 510.6% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 67,803 shares of the technology company’s stock valued at $563,000 after purchasing an additional 56,699 shares during the last quarter. Finally, Quantbot Technologies LP purchased a new position in shares of Stratasys during the 3rd quarter worth $90,000. 75.77% of the stock is owned by institutional investors and hedge funds.

Stratasys Company Profile

Stratasys Ltd. provides connected polymer-based 3D printing solutions. It offers range of 3D printing systems, which includes polyjet printer, Fused Deposition Modeling (FDM) printers, stereolithography printing systems, origin P3 printers, and selective absorption fusion printer for additive manufacturing, and tooling and rapid prototyping for various vertical markets, such as automotive, aerospace, consumer products and healthcare.